Gene · 1749
Papers1,688
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,688
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Peonidin-3-O-glucoside and Resveratrol Increase the Viability of Cultured Human hFOB Osteoblasts and Alter the Expression of Genes Associated with Apoptosis, Osteoblast Differentiation and Osteoclastogenesis. | Nutrients | 2023 | 37513651 | PubTator, text mining | PubMed |
| Astaxanthin as a Potent Antioxidant for Promoting Bone Health: An Up-to-Date Review. | Antioxidants (Basel) | 2023 | 37508018 | PubTator, text mining | PubMed |
| GEMIN4, a potential therapeutic targets for patients with basal-like subtype breast cancer. | BMC Womens Health | 2023 | 37507701 | PubTator, text mining | PubMed |
| MFNG is an independent prognostic marker for osteosarcoma. | Eur J Med Res | 2023 | 37496053 | PubTator, text mining | PubMed |
| A ubiquitin-based effector-to-inhibitor switch coordinates early brain, craniofacial, and skin development. | Nat Commun | 2023 | 37495603 | PubTator, text mining | PubMed |
| Additional Depth to the NMDA Receptor Hypofunction and Parvalbumin Cell Dysfunction Hypotheses of Schizophrenia. | Biol Psychiatry | 2023 | 37495331 | PubTator, text mining | PubMed |
| DLX5 promotes Col10a1 expression and chondrocyte hypertrophy and is involved in osteoarthritis progression. | Genes Dis | 2023 | 37492739 | PubTator, text mining | PubMed |
| Retraction Note: Polydatin improves osteogenic differentiation of human bone mesenchymal stem cells by stimulating TAZ expression via BMP2-Wnt/β-catenin signaling pathway. | Stem Cell Res Ther | 2023 | 37491378 | PubTator, text mining | PubMed |
| Deer antler renewal gives insights into mammalian epimorphic regeneration. | Cell Regen | 2023 | 37490254 | PubTator, text mining | PubMed |
| Hypertrophic chondrocytes at the junction of musculoskeletal structures. | Bone Rep | 2023 | 37485234 | PubTator, text mining | PubMed |
| Long non-coding RNA CASC2 regulates osteoblasts matrix mineralization. | Front Bioeng Biotechnol | 2023 | 37469450 | PubTator, text mining | PubMed |
| Epigenetic regulation of bone remodeling and its role in the pathogenesis of primary osteoporosis. | Vavilovskii Zhurnal Genet Selektsii | 2023 | 37465189 | PubTator, text mining | PubMed |
| Integration of Transcriptome and MicroRNA Profile Analysis of iMSCs Defines Their Rejuvenated State and Conveys Them into a Novel Resource for Cell Therapy in Osteoarthritis. | Cells | 2023 | 37443790 | PubTator, text mining | PubMed |
| Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies. | MedComm (2020) | 2023 | 37441462 | PubTator, text mining | PubMed |
| Extracellular matrix-derived peptide stimulates the generation of endocrine progenitors and islet organoids from iPSCs. | J Tissue Eng | 2023 | 37435573 | PubTator, text mining | PubMed |
| The tumor suppressor CREBBP and the oncogene MYCN cooperate to induce malignant brain tumors in mice. | Oncogenesis | 2023 | 37407554 | PubTator, text mining | PubMed |
| Comprehensive analysis of distal-less homeobox family gene expression in colon cancer. | World J Gastrointest Oncol | 2023 | 37389108 | PubTator, text mining | PubMed |
| Enhanced osteogenesis of human urine-derived stem cells by direct delivery of 30Kc19α-Lin28A protein. | Front Bioeng Biotechnol | 2023 | 37383520 | PubTator, text mining | PubMed |
| Human prostate organoid generation and the identification of prostate development drivers using inductive rodent tissues. | Development | 2023 | 37376888 | PubTator, text mining | PubMed |
| 3D-Printed PLA Scaffold with Fibronectin Enhances In Vitro Osteogenesis. | Polymers (Basel) | 2023 | 37376267 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1749/papers?page=8